AAN: American Academy of Neurology
American Academy of Neurology (AAN): Annual Meeting
Conference Coverage
Some MS treatments may heighten COVID risk
An Italian registry shows worse outcomes with anti-CD20 treatment, but a possible protective effect of interferon and teriflunomide.
Conference Coverage
VNS plus rehab is a powerful poststroke combination
An analysis found that outcomes for vagus nerve stimulation combined with rehabilitation for poststroke arm weakness exceeded rehabilitation alone...
Conference Coverage
More reassurance for certain antiseizure drugs in pregnancy
Results show “no difference in verbal index or general conceptual ability scores in children born to women with epilepsy compared to children born...
Conference Coverage
Are psychiatric disorders a ‘canary in a coal mine’ for Alzheimer’s disease?
A chart review of 1,500 patients with Alzheimer’s disease identified a potential link between psychiatric disorders and younger onset of disease...
Conference Coverage
Long-term benefit for DBS in treating Parkinson’s disease motor symptoms
“Both STN and GPi DBS maintained motor benefit out to 10 years, with improvements seen in tremor and rigidity, greater than bradykinesia.”
Conference Coverage
COVID-19 linked to novel epileptic seizures
Among patients with new-onset seizures, hospital stays were about 15 days longer – and mortality rates were significantly higher.
Conference Coverage
Intranasal third-generation CGRP effective for acute migraine
Among patients taking zavegepant, more than 20% achieved pain freedom and 40% were relieved of their most bothersome symptom.
Conference Coverage
Evobrutinib may lower nerve damage biomarker levels
A post hoc analysis reports the Bruton’s tyrosine kinase inhibitor evobrutinib lowered neurofilament light chain blood levels in multiple...
Conference Coverage
Cannabis for migraine strongly linked to rebound headache
Are patients using cannabis to treat medication overuse headache, or is cannabis contributing to the development of said headaches, or both?
Conference Coverage
Nondopamine antipsychotic shows clinical signal in Parkinson’s disease psychosis
Investigative schizophrenia drug SEP-363856 showed improvement in psychotic symptoms in Parkinson’s without worsening motor function.
Conference Coverage
Gene therapy shows promise for Sanfilippo syndrome
Children who began treatment at younger age fared particularly well.
Conference Coverage
Investigative gepant liver profile comparable with standard of care
The investigative oral chronic migraine therapy atogepant had 1-year side-effect and hepatic function profiles comparable with the standard of...
Conference Coverage
The neurology of long-haul COVID-19
Clinical patterns and pathology are beginning to hint at the biology behind persistent neurologic complaints.
Conference Coverage
Stroke is ‘not a common complication’ in COVID-19
Among the sickest of COVID patients – those admitted to an ICU – researchers found that stroke was not a common complication.
Conference Coverage
Study shows potential of remote Parkinson’s disease genotyping
A pilot study finds that remote genetic testing and counseling in Parkinson’s disease may have potential for casting a wider net for genetic data...